Dogwood Therapeutics DWTX Interest Expense
Interest Expense at other companies
Other financials
Where this comes from
Reported directly by Dogwood Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:InterestIncomeExpenseNonoperatingNet.
The official record: Dogwood Therapeutics’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →
Ask your AI about Dogwood Therapeutics's interest expense.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Dogwood Therapeutics's interest expense?
- Dogwood Therapeutics (DWTX) reported interest expense of $77.35K in Q1 2026.
- How has Dogwood Therapeutics's interest expense changed year-over-year?
- Dogwood Therapeutics's interest expense increased by 152.6% year-over-year, from -$147.09K to $77.35K.
- What is the long-term trend for Dogwood Therapeutics's interest expense?
- Over 2 years (2023 to 2025), Dogwood Therapeutics's interest expense has grown at a -19.9% compound annual growth rate (CAGR), from $150.9K to $96.94K.
- What does interest expense mean?
- Cost of borrowing — interest paid or accrued on bonds, bank loans, credit facilities, finance leases, and other debt obligations.